ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,152 | -75.0% | 77,023 | -3.3% | 0.01% | -71.9% |
| Q2 2023 | $40,611 | -21.2% | 79,630 | -2.7% | 0.03% | -11.1% |
| Q1 2023 | $51,553 | -25.0% | 81,830 | -22.7% | 0.04% | -25.0% |
| Q4 2022 | $68,733 | -65.8% | 105,890 | -9.4% | 0.05% | -64.4% |
| Q3 2022 | $201,000 | +30.5% | 116,860 | -6.2% | 0.14% | +39.2% |
| Q2 2022 | $154,000 | +62.1% | 124,560 | -14.1% | 0.10% | +61.7% |
| Q1 2022 | $95,000 | -26.9% | 144,960 | +21.5% | 0.06% | -36.2% |
| Q4 2021 | $130,000 | -63.9% | 119,320 | -39.7% | 0.09% | -64.3% |
| Q3 2021 | $360,000 | -32.2% | 198,002 | -1.5% | 0.26% | -40.5% |
| Q2 2021 | $531,000 | -26.1% | 200,962 | +0.6% | 0.44% | -27.5% |
| Q1 2021 | $719,000 | +41.8% | 199,802 | -0.6% | 0.61% | +46.3% |
| Q4 2020 | $507,000 | -0.2% | 201,002 | -0.2% | 0.42% | +2.0% |
| Q3 2020 | $508,000 | – | 201,470 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |